Health department

Children’s Home Society’s Institute for Family Honors Social Workers with Family Champion Awards

Retrieved on: 
Mittwoch, Mai 29, 2024
Parent, Education, Department of Social Services, Social, Health equity, CHS, Social services, Social work, Engagement, MSW, Duke, Child, Family, Health department

Greensboro, NC, May 29, 2024 (GLOBE NEWSWIRE) -- The Institute for Family, an entity of Children’s Home Society of NC (CHS), presented its second annual Family Champion Awards on April 26 at The Duke Endowment in Charlotte, NC.

Key Points: 
  • Greensboro, NC, May 29, 2024 (GLOBE NEWSWIRE) -- The Institute for Family, an entity of Children’s Home Society of NC (CHS), presented its second annual Family Champion Awards on April 26 at The Duke Endowment in Charlotte, NC.
  • Social workers and family advocates from across North Carolina gathered to honor social workers for the vital role they play in promoting family well-being.
  • The Institute for Family advocates for family well-being in North Carolina and across the nation.
  • The Institute capitalizes on Children’s Home Society’s 120-year history of providing direct services for families associated with the child welfare system.

Glenwood Regional Medical Center’s Status Restored by CMS and Fully Operational

Retrieved on: 
Dienstag, Mai 14, 2024
Health, Hospitals, Quality, Patient, CMS, Medicare, News, Health department, Nursing

Glenwood Regional Medical Center has been deemed to be in compliance with all relevant requirements by the Louisiana Department of Health, who also restored the status of the hospital.

Key Points: 
  • Glenwood Regional Medical Center has been deemed to be in compliance with all relevant requirements by the Louisiana Department of Health, who also restored the status of the hospital.
  • After a period of regulatory review, the Health Department and the Centers for Medicare and Medicaid Services (CMS) found that the hospital’s compliance plans addressed all previously noted issues and allowed the facility to be transferred to its usual status.
  • Glenwood is fully operational and continues to be open to serve patients and the community every day.
  • “I’m very proud to share the news that Glenwood Regional Medical Center’s status has been fully restored after our staff and leadership worked collaboratively with state and federal regulators.

Washington Selects Fusion Health as State-Approved EHR Vendor

Retrieved on: 
Montag, April 29, 2024
DCYF, Case management, Pharmacy, Social, DOC, Hope, Improper integral, Florida Department, HCA, Washington State University, EHR, Evergreen State College, Health department, Emar, DSHS, DOH, Corrections, Nursing

WOODBRIDGE, N.J., April 29, 2024 /PRNewswire/ -- Fusion Health, a leading provider of specialized EHR and pharmacy management solutions for corrections, psychiatric hospitals, and other complex care movement-restricted environments, has been selected as an approved EHR vendor by the Washington State Department of Enterprise Services (DES). This contract (Statewide Contract #23023) allows state, county, and local agencies across Washington to streamline the process of procuring Fusion's healthcare technology solutions.

Key Points: 
  • WOODBRIDGE, N.J., April 29, 2024 /PRNewswire/ -- Fusion Health, a leading provider of specialized EHR and pharmacy management solutions for corrections, psychiatric hospitals, and other complex care movement-restricted environments, has been selected as an approved EHR vendor by the Washington State Department of Enterprise Services (DES).
  • Fusion can now be tapped as a preferred Washington State vendor to provide solutions for numerous, varied agencies across Washington, including but not limited to the Department of Social and Health Services (DSHS), Health Care Authority (HCA), Department of Children, Youth, and Families (DCYF), Department of Health (DOH), and Department of Corrections (DOC).
  • "We're thrilled to be recognized by the Washington State Department of Enterprise Services," said Bryan Jakovcic, CEO and founder of Fusion Health.
  • It also positions us to expand our reach and serve more agencies throughout Washington State dedicated to improving patient care."

Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab

Retrieved on: 
Donnerstag, April 25, 2024
PFS, Shirin David, JAMA, Risk, NDA, Government, Progression-free survival, New Drug Application, American Medical Association, Cisplatin, Death, Immunotherapy, Trial of the century, ASCO, European, Health department, Dor, Patient, Nasopharyngeal carcinoma, Society, NPC, Marketing, Clutch (eggs), Journal, Pharmaceutical industry

Toripalimab plus chemotherapy also reduced the risk of disease progression or death by 48% and the risk of death by 37%, all while demonstrating a manageable safety profile.

Key Points: 
  • Toripalimab plus chemotherapy also reduced the risk of disease progression or death by 48% and the risk of death by 37%, all while demonstrating a manageable safety profile.
  • So far, toripalimab has been approved for marketing in the Chinese mainland and the US.
  • Several NDAs are currently under regulatory review in the European Union, UK, Australia, Singapore, Malaysia and Hong Kong Special Administrative Region (“SAR”).
  • Furthermore, NDAs for toripalimab have also been submitted in India, South Africa, Chile and Jordan.

C2Sense® and Princeton BioMeditech Receive Second Award from NIH RADx® Tech High Performance Program for Digitally Connected, At-Home Diagnostic Reader and Multiplex COVID-19/Flu A&B Rapid Test

Retrieved on: 
Dienstag, April 9, 2024
Medical imaging, ACME, Halo, Human services, SARS-CoV-2, NIH, Acceleration, Clinical trial, National Institutes of Health, POC, BBC, Omicron, Biological engineering, Bangladesh Technical Education Board, Federal, Health department, PBM, Princeton University

The companies are currently planning their upcoming clinical trial, regulatory submission, and transfer to manufacture.

Key Points: 
  • The companies are currently planning their upcoming clinical trial, regulatory submission, and transfer to manufacture.
  • "After rigorous testing and intensive data collection, Halo®, used in conjunction with the PBM multiplex rapid test, continues to demonstrate outstanding sensitivity and reliability," said Jason Cox, Ph.D., CEO at C2Sense.
  • "Powered by our latest algorithm release, the price vs. performance of our Halo reader is unparalleled."
  • As always, we remain committed to providing our customers with the best possible solution for at-home testing," added Cox.

In coordination with DoH J.P. Morgan's Life Sciences Private Capital announces Life Sciences Innovation Summit 2024 finalists ahead of ADGHW

Retrieved on: 
Freitag, April 5, 2024
Health, Abu Dhabi Executive Council, Prevalence, Executive, Doctor of Philosophy, Cleveland Clinic, Creativity, Emirate, Doh, Health department

ABU DHABI, UAE, April 5, 2024 /PRNewswire/ -- Taking place on the sidelines of Abu Dhabi Global Healthcare Week (ADGHW), hosted by the Department of Health – Abu Dhabi (DoH ), the regulator of the healthcare sector in the Emirate, J.P. Morgan Asset Management's Life Sciences Private Capital, Blue Horizon Advisors and United AlSaqer Group announce the 11 finalists of the inaugural Life Sciences Innovation Summit 2024 on May 14 – 15, 2024.

Key Points: 
  • ABU DHABI, UAE, April 5, 2024 /PRNewswire/ -- Taking place on the sidelines of Abu Dhabi Global Healthcare Week (ADGHW), hosted by the Department of Health – Abu Dhabi (DoH ), the regulator of the healthcare sector in the Emirate, J.P. Morgan Asset Management's Life Sciences Private Capital, Blue Horizon Advisors and United AlSaqer Group announce the 11 finalists of the inaugural Life Sciences Innovation Summit 2024 on May 14 – 15, 2024.
  • The finalists were selected from a pool of exceptional candidates across more than 20 countries and represent a diverse range of companies and research institutions developing innovative therapeutic solutions.
  • With over 150 highly qualified applications submitted from around the globe, clearly the medical research and innovation community is paying attention to this event."
  • The event seeks to accelerate collaboration, innovation, and investment, and bring together researchers, policymakers, healthcare specialists, investors, and entrepreneurs across the global healthcare and life-science ecosystem.

In coordination with DoH J.P. Morgan's Life Sciences Private Capital announces Life Sciences Innovation Summit 2024 finalists ahead of ADGHW

Retrieved on: 
Freitag, April 5, 2024
Health, Abu Dhabi Executive Council, Prevalence, Executive, Doctor of Philosophy, Cleveland Clinic, Creativity, Emirate, Doh, Multimedia, Health department

ABU DHABI, UAE, April 5, 2024 /PRNewswire/ -- Taking place on the sidelines of Abu Dhabi Global Healthcare Week (ADGHW), hosted by the Department of Health – Abu Dhabi (DoH ), the regulator of the healthcare sector in the Emirate, J.P. Morgan Asset Management's Life Sciences Private Capital, Blue Horizon Advisors and United AlSaqer Group announce the 11 finalists of the inaugural Life Sciences Innovation Summit 2024 on May 14 – 15, 2024.

Key Points: 
  • ABU DHABI, UAE, April 5, 2024 /PRNewswire/ -- Taking place on the sidelines of Abu Dhabi Global Healthcare Week (ADGHW), hosted by the Department of Health – Abu Dhabi (DoH ), the regulator of the healthcare sector in the Emirate, J.P. Morgan Asset Management's Life Sciences Private Capital, Blue Horizon Advisors and United AlSaqer Group announce the 11 finalists of the inaugural Life Sciences Innovation Summit 2024 on May 14 – 15, 2024.
  • The finalists were selected from a pool of exceptional candidates across more than 20 countries and represent a diverse range of companies and research institutions developing innovative therapeutic solutions.
  • With over 150 highly qualified applications submitted from around the globe, clearly the medical research and innovation community is paying attention to this event."
  • Abu Dhabi Global Healthcare Week aims to bring together innovators, investors and industry leaders to explore the latest advancements and trends shaping the future of healthcare.

J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United AlSaqer Group Announce Finalists of the 2024 Life Sciences Innovation Summit in Abu Dhabi

Retrieved on: 
Donnerstag, April 4, 2024
Research, Prevalence, Cleveland Clinic Abu Dhabi, Cleveland Clinic, Creativity, JPMorgan Chase, Health department, Amusement park

NEW YORK, April 4, 2024 /PRNewswire/ -- J.P. Morgan Asset Management's Life Sciences Private Capital, Blue Horizon Advisors and United AlSaqer Group are pleased to announce the 11 finalists of the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit .

Key Points: 
  • NEW YORK, April 4, 2024 /PRNewswire/ -- J.P. Morgan Asset Management's Life Sciences Private Capital, Blue Horizon Advisors and United AlSaqer Group are pleased to announce the 11 finalists of the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit .
  • The summit will take place on May 14-15, 2024 at Cleveland Clinic Abu Dhabi during Abu Dhabi Global Healthcare Week.
  • The Department of Health - Abu Dhabi is sponsoring the event, aiming to bring together innovators, investors and industry leaders to explore the latest advancements and trends shaping the future of healthcare.
  • "We are very pleased to be partnering with the stellar leadership of the Department of Health - Abu Dhabi, Blue Horizon Advisors, United AlSaqer Group, Cleveland Clinic Abu Dhabi and other local leaders in launching our inaugural innovation summit," said Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital.

Salmonella outbreak leads to Canada-wide class action lawsuit

Retrieved on: 
Montag, Januar 8, 2024
Food, Salmonellosis, Risk, Death, Public Health Agency, Person, Canadian Food Inspection Agency, Health department, Eating, Pregnancy, Health Canada, CBC, Dietary supplement

According to the CBC , Mexico's Health Department ordered the temporary closure of a melon-packing plant linked to the outbreak on December 15, 2023.

Key Points: 
  • According to the CBC , Mexico's Health Department ordered the temporary closure of a melon-packing plant linked to the outbreak on December 15, 2023.
  • The Public Health Agency of Canada announced on December 22, 2023 that there have been 164 laboratory-confirmed cases of Salmonella infections, 61 hospitalizations and seven deaths in Canada related to this outbreak.
  • Slater Vecchio LLP previously initiated a class action on behalf of residents of Québec on December 12, 2023 in response to this Salmonella outbreak.
  • Slater Vecchio LLP is seeking to identify individuals who purchased a recalled cantaloupe or related product sold after October 10, 2023.

ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs

Retrieved on: 
Donnerstag, November 30, 2023
Research, Infectious Diseases, Clinical Trials, Stem Cells, Biotechnology, AIDS, General Health, Pharmaceutical, Health, Science, NIAID, HIV/AIDS, Biology, Vaccine, DVM, Infection, National Institutes of Health, Human services, HIV, NIH, MBA, Contract research organization, Bangladesh Technical Education Board, Health department, Public, Pharmaceutical industry, ATCC

NIAID has made an initial award of over $21.5 million, with further funding expected if all project milestones are met.

Key Points: 
  • NIAID has made an initial award of over $21.5 million, with further funding expected if all project milestones are met.
  • This contract will merge the NIH HIV Reagent Program with the BEI Resources Program under the Biological and Emerging Infections Research Resources Program (BEI-RRP) umbrella.
  • ATCC has managed the BEI Resources Program since 2003 and the NIH HIV Reagent Program since 2020.
  • At the discretion of NIAID, it will also be a resource for materials produced by other government-supported research projects and service programs.